📰 Catalyst Pathways News
Catalyst Pathways News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Catalyst Pathways. Real-time updates on events, politics, business and more.
May 10, 2022
10.05.2022 - Achieved Record Revenues of more than $43 Million, a 42.7% Increase YoY Three New Patents Issued; Now Five Orange-Book Listed Patents for FIRDAPSE Significant Cash Position of $198 Million and No Funded Debt Advanced Plans to Diversify and ...
February 4, 2022
The FDA's marketing approval of Jacobus Pharmaceutical’s Ruzurgi (amifampridine) for Lambert-Eaton myasthenic syndrome in pediatric patients is no longer valid.
January 10, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
May 11, 2021
Greetings and welcome to the Catalyst Pharmaceuticals First Quarter 2021 Results Conference Call. [Operator Instructions] It is now my pleasure to introduce your host, Ms. Alicia Grande, Vice President, Chief Financial Officer and Treasurer. Thank you. You may begin. Alicia Grande -- Vice President, Chief Financial Officer and Treasurer Good morning, everyone, and thank you for joining our conference call to discuss Catalysts first quarter 2021 financial results and corporate highlights. Leadi...